Cold autoimmune hemolytic anemia: Difference between revisions

From WikiMD's Medical Encyclopedia

CSV import
 
CSV import
 
(One intermediate revision by the same user not shown)
Line 1: Line 1:
'''Cold Autoimmune Hemolytic Anemia''' (CAHA) is a type of [[anemia]] characterized by the body's immune system attacking and destroying its own red blood cells at cold temperatures. This condition is a subtype of [[Autoimmune Hemolytic Anemia]] (AIHA), which is a group of disorders where the immune system mistakenly identifies red blood cells as foreign substances and destroys them.
== Causes ==
CAHA is often caused by an underlying condition such as [[infection]], [[lymphoma]], or [[autoimmune disease]]. It can also occur as a result of exposure to certain drugs or chemicals. In some cases, the cause of CAHA is unknown, a condition referred to as [[idiopathic]] CAHA.


{{Infobox medical condition
| name            = Cold autoimmune hemolytic anemia
| synonyms        = Cold agglutinin disease
| field          = [[Hematology]]
| symptoms        = [[Fatigue (medical)|Fatigue]], [[pallor]], [[jaundice]], [[dark urine]], [[cold-induced acrocyanosis]]
| complications  = [[Anemia]], [[Raynaud's phenomenon]], [[hemolytic crisis]]
| onset          = Typically in [[adulthood]]
| duration        = Chronic
| causes          = [[Autoimmune disease]], often idiopathic or secondary to infections or other conditions
| risks          = [[Infections]], [[lymphoproliferative disorders]]
| diagnosis      = [[Direct Coombs test]], [[blood smear]], [[cold agglutinin titer]]
| differential    = [[Warm autoimmune hemolytic anemia]], [[paroxysmal cold hemoglobinuria]], [[cryoglobulinemia]]
| treatment      = [[Avoidance of cold]], [[rituximab]], [[corticosteroids]], [[plasmapheresis]]
| prognosis      = Variable, depends on underlying cause and response to treatment
| frequency      = Rare
}}
== Cold Autoimmune Hemolytic Anemia ==
'''Cold Autoimmune Hemolytic Anemia''' (CAHA) is a rare type of [[autoimmune hemolytic anemia]] (AIHA) characterized by the premature destruction of [[red blood cells]] (RBCs) at low temperatures. This condition is mediated by [[autoantibodies]] that bind to RBCs, leading to their destruction by the [[immune system]].
== Pathophysiology ==
In CAHA, the immune system produces [[cold agglutinins]], which are antibodies that react with RBCs at temperatures below normal body temperature, typically between 0°C and 30°C. These antibodies are usually of the [[IgM]] class and can cause RBCs to clump together (agglutinate) and be destroyed, primarily in the [[liver]] and [[spleen]].
== Symptoms ==
== Symptoms ==
The symptoms of CAHA can vary widely, but often include fatigue, weakness, pale skin, cold hands and feet, and dark urine. In severe cases, it can lead to [[jaundice]], [[heart failure]], or even death.
The symptoms of CAHA can vary depending on the severity of the condition and the degree of hemolysis. Common symptoms include:
 
* [[Fatigue]]
* [[Pallor]]
* [[Jaundice]]
* [[Dark urine]]
* [[Cold-induced acrocyanosis]]
== Diagnosis ==
== Diagnosis ==
Diagnosis of CAHA typically involves a series of blood tests, including a [[complete blood count]] (CBC), [[reticulocyte count]], and [[direct antiglobulin test]] (DAT). In some cases, a [[bone marrow biopsy]] may be necessary to rule out other conditions.
Diagnosis of CAHA involves several laboratory tests, including:
 
* [[Complete blood count]] (CBC) showing anemia
* [[Direct Coombs test]] (direct antiglobulin test) positive for complement
* Detection of cold agglutinins in the blood
* [[Blood smear]] showing agglutinated RBCs
== Treatment ==
== Treatment ==
Treatment for CAHA is primarily aimed at managing symptoms and treating the underlying cause, if known. This may involve [[immunosuppressive therapy]], [[plasmapheresis]], or in severe cases, [[splenectomy]].
Treatment of CAHA focuses on managing symptoms and preventing hemolysis. Strategies include:
 
* Avoiding exposure to cold temperatures
* Use of [[immunosuppressive drugs]] such as [[rituximab]]
* [[Plasmapheresis]] in severe cases
== Prognosis ==
== Prognosis ==
The prognosis for individuals with CAHA varies widely and depends on the severity of the condition and the success of treatment. With appropriate treatment, many individuals with CAHA can lead normal, healthy lives.
The prognosis for individuals with CAHA varies. Some patients may experience mild symptoms, while others may have severe anemia requiring medical intervention. The condition can be chronic, with periods of remission and exacerbation.
 
== See Also ==
[[File:Cold Autoimmune Hemolytic Anemia.jpg|thumb|right|Micrograph showing red blood cell destruction in CAHA]]
* [[Autoimmune hemolytic anemia]]
 
== See also ==
* [[Warm autoimmune hemolytic anemia]]
* [[Warm autoimmune hemolytic anemia]]
* [[Paroxysmal cold hemoglobinuria]]
* [[Hemolytic anemia]]
* [[Hemolytic disease of the newborn]]
 
== References ==
== References ==
<references />
* {{Cite journal |last1=Berentsen |first1=S. |title=Cold agglutinin disease |journal=Hematology |year=2016 |volume=2016 |issue=1 |pages=226-231 |doi=10.1182/asheducation-2016.1.226}}
 
* {{Cite book |last1=Hoffbrand |first1=A. V. |title=Hoffbrand's Essential Haematology |edition=7th |year=2016 |publisher=Wiley-Blackwell |isbn=978-1118408674}}
== External Links ==
* [https://www.mayoclinic.org/diseases-conditions/autoimmune-hemolytic-anemia/symptoms-causes/syc-20355609 Mayo Clinic - Autoimmune Hemolytic Anemia]
[[Category:Hematology]]
[[Category:Autoimmune diseases]]
[[Category:Blood disorders]]
[[Category:Blood disorders]]
[[Category:Autoimmune diseases]]
[[Category:Hematology]]
{{medicine-stub}}

Latest revision as of 05:54, 4 April 2025


Cold autoimmune hemolytic anemia
Synonyms Cold agglutinin disease
Pronounce N/A
Specialty N/A
Symptoms Fatigue, pallor, jaundice, dark urine, cold-induced acrocyanosis
Complications Anemia, Raynaud's phenomenon, hemolytic crisis
Onset Typically in adulthood
Duration Chronic
Types N/A
Causes Autoimmune disease, often idiopathic or secondary to infections or other conditions
Risks Infections, lymphoproliferative disorders
Diagnosis Direct Coombs test, blood smear, cold agglutinin titer
Differential diagnosis Warm autoimmune hemolytic anemia, paroxysmal cold hemoglobinuria, cryoglobulinemia
Prevention N/A
Treatment Avoidance of cold, rituximab, corticosteroids, plasmapheresis
Medication N/A
Prognosis Variable, depends on underlying cause and response to treatment
Frequency Rare
Deaths N/A


Cold Autoimmune Hemolytic Anemia[edit]

Cold Autoimmune Hemolytic Anemia (CAHA) is a rare type of autoimmune hemolytic anemia (AIHA) characterized by the premature destruction of red blood cells (RBCs) at low temperatures. This condition is mediated by autoantibodies that bind to RBCs, leading to their destruction by the immune system.

Pathophysiology[edit]

In CAHA, the immune system produces cold agglutinins, which are antibodies that react with RBCs at temperatures below normal body temperature, typically between 0°C and 30°C. These antibodies are usually of the IgM class and can cause RBCs to clump together (agglutinate) and be destroyed, primarily in the liver and spleen.

Symptoms[edit]

The symptoms of CAHA can vary depending on the severity of the condition and the degree of hemolysis. Common symptoms include:

Diagnosis[edit]

Diagnosis of CAHA involves several laboratory tests, including:

Treatment[edit]

Treatment of CAHA focuses on managing symptoms and preventing hemolysis. Strategies include:

Prognosis[edit]

The prognosis for individuals with CAHA varies. Some patients may experience mild symptoms, while others may have severe anemia requiring medical intervention. The condition can be chronic, with periods of remission and exacerbation.

See Also[edit]

References[edit]

  • ,
 Cold agglutinin disease, 
 Hematology, 
 2016,
 Vol. 2016(Issue: 1),
 pp. 226-231,
 DOI: 10.1182/asheducation-2016.1.226,
  • ,
 Hoffbrand's Essential Haematology, 
 7th edition, 
 Wiley-Blackwell, 
 2016, 
  
  
 ISBN 978-1118408674,

External Links[edit]

Retrieved from "https://wikimd.org/index.php?title=Cold_autoimmune_hemolytic_anemia&oldid=6543977"